# Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

> **NCT03125616** · PHASE4 · COMPLETED · sponsor: **St George's, University of London** · enrollment: 136 (actual)

## Conditions studied

- Prematurity
- Vaccination
- Meningococcal Disease

## Interventions

- **BIOLOGICAL:** 4CMenB Vaccine
- **BIOLOGICAL:** 4CMenB Vaccine
- **BIOLOGICAL:** 4CMenB Vaccine
- **BIOLOGICAL:** 4CMenB Vaccine

## Key facts

- **NCT ID:** NCT03125616
- **Lead sponsor:** St George's, University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2019-09-02
- **Final completion:** 2020-08-28
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2020-12-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03125616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03125616, "Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03125616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*